Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver disease
Pharma
Madrigal's first-ever MASH drug beats sales projections again
Addressing the potential competition from semaglutide, Madrigal's CEO said Novo is gunning for “multiples” the size of Rezdiffra’s target population.
Angus Liu
May 2, 2025 11:00am
Ipsen touts early launch results for liver disease drug Iqirvo
Apr 17, 2025 8:47am
EU authorities revoke marketing nod for Advanz Pharma's Ocaliva
Dec 2, 2024 2:54pm
FDA shoots down Intercept's bid for full approval of Ocaliva
Nov 12, 2024 2:12pm
Intercept's Ocaliva nod in danger after negative FDA adcomm vote
Sep 16, 2024 10:40am
Ocaliva's fate looks bleak after FDA releases new briefing docs
Sep 11, 2024 4:58pm
